They won't last until after the interim analysis.
Had 5.7m at end of September qtr with a 2.2m quarterly spend. So roughly 3.5m end of December. Money will be required very soon given less than two quarters remaining, wouldn't be surprised if there were a raise in the upcoming couple weeks.
- Forums
- ASX - By Stock
- ATX
- Ann: FDA Clearance Amplia's IND for Pancreatic Cancer Trial in US
Ann: FDA Clearance Amplia's IND for Pancreatic Cancer Trial in US, page-22
Featured News
Add ATX (ASX) to my watchlist
|
|||||
Last
6.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.83M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 66032 | 6.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.6¢ | 83586 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 66032 | 0.061 |
3 | 103326 | 0.059 |
1 | 85991 | 0.058 |
1 | 42105 | 0.057 |
3 | 233928 | 0.056 |
Price($) | Vol. | No. |
---|---|---|
0.066 | 83586 | 1 |
0.070 | 6009 | 1 |
0.074 | 73026 | 1 |
0.075 | 335646 | 1 |
0.081 | 100000 | 1 |
Last trade - 16.12pm 01/07/2024 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online